Order Now 1-800-246-8878

DiaCarta technologies deliver faster, more sensitive results for diagnostic and molecular genetic testing.

Services Overview

CLIA Lab Services

DiaCarta’s state-of-the-art GMP-compliant lab space is over 18,000 square feet. With CA CLIA certifications, DiaCarta is dedicated to providing the highest quality facilities that are capable of manufacturing the most advanced molecular diagnostic tools.

Learn More


OptiSeq™ NGS Target Sequencing Platform

DiaCart’s OptiSeq™ platform is based on next-generation sequencing — cutting-edge technology that allows cancer genomes to be proled very quickly and with great sensitivity.

Learn More


Next-Gen Sequencing Service

DiaCarta’s Next-Gen Sequencing service is an end to end solution for your tissue and liquid biopsy samples. With a streamlined workflow and dedicated in-house team, we offer quick turnaround time from sample to result.

Learn More


Companion Diagnostics

DiaCarta offers a range of customizable testing services. From single-gene QClamp® qPCR tests to QClamp-NGS panels, DiaCarta is committed to providing companion diagnostic development services customized to fit your needs. Additionally, DiaCarta offers unique project management services to ensure your project is completed in a timely manner and ready for regulatory submission.

Learn More


Personalized CAR-T Immunotherapy Platform

In the era of the Cancer MoonShot 2020 Program – the nation’s most comprehensive cancer collaborative initiative to accelerate the potential of combination immunotherapy as the next generation standard of care in cancer patients, DiaCarta and ProMab have joined hands to offer the next-generation Chimeric Antigen Receptor T-Cell (CAR-T) immunotherapy platform.

Learn More